April 25 (Reuters) - The U.S. Food and Drug Administration on Thursday sent a warning letter to Cardinal Health after an inspection of its facility in Illinois showed that the company was marketing unapproved devices. (Reporting by Pratik Jain in Bengaluru)
US FDA sends warning to Cardinal Health for marketing unapproved devices
![Reuters logo](/images/reuters.jpg)